 |
|
|
| |
Resource Utilization During Hepatitis C Treatment With Boceprevir- or Telaprevir-Based Triple Therapy vs Dual Therapy In A Large Health Maintenance Organization
|
| |
| |
Reported by Jules Levin
Digestive Disease Week, May 3-6, 2014, Chicago, IL
Anders H. Nyberg1, Kevin M. Chiang2, Zhaoliang Li2, Zobair M. Younossi3, T. Craig Cheetham4, Lisa M. Nyberg1
1Hepatology Research, Kaiser Permanente, San Diego, CA, United States; 2Pharmacy Analytical Services, Kaiser Permanente, Downey, CA, United States; 3Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, United States; 4Kaiser Permanente Department of Research and Evaluation, Pasadena, CA
|
| |
|
|
|
|
|
